Fractional Leadership for Life Sciences

• Emerging and established biotech companies Biopharma  – preparing for initial  launch or scaling up for growth

• Medical technology and medical device companies – scaling up into new markets

• Venture capital and private equity firms – requiring commercial due diligence and portfolio growth support

Key Statistics

 25+ years of leadership  |  4 start-ups built  |  5+ major launches  |  15+ therapeutic areas

Oncology

Led the first oncology launch for a global biotech—building affiliate operations, establishing a patient support program, and securing reimbursement—achieving full launch readiness in just nine months, far ahead of industry norms.

HIV

Reversed post-launch decline by repositioning the brand, redesigning the patient hub, and refocusing the commercial team—driving renewed growth and aligning sales with market expectations.

Immunology

In a crowded, mature market, restructured the commercial team and revamped a patient support program serving thousands—delivering >20% year-over-year growth despite dominant competitors.

• Fractional Executive: 1–3 days per week for ongoing leadership support.

• Interim Leadership: Cover General Manager or Chief Commercial Officer roles during organizational transitions.

• Project-Based Consulting: Focused engagements for launch readiness, market access, or turnaround initiatives.